Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.

Eli Lilly and Company (NYSE: LLY) is one of two pharmaceutical stocks behind the weight loss drug craze that has impacted the ...

A small study confirms observations what users have observed: the medications reduce their cravings for alcohol.

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.